title: Is raloxifene the answer to the HRT story?
authors.forename: B
authors.initials: B
authors.lastname: Apgar
mesh_terms: D001842:Bone and Bones / Q000187:drug effects; D001943:Breast Neoplasms / Q000139:chemically induced / Q000517:prevention & control; D002319:Cardiovascular System / Q000187:drug effects; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D004967:Estrogens / Q000009:adverse effects / Q000819:agonists*; D005194:Family Practice; D005260:Female; D006801:Humans; D010353:Patient Education as Topic; D010880:Piperidines / Q000627:therapeutic use*; D017698:Postmenopause; D020849:Raloxifene Hydrochloride; D011960:Receptors, Estrogen / Q000187:drug effects*; D014481:United States
chemical_list: D004967:Estrogens; D010880:Piperidines; D011960:Receptors, Estrogen; D020849:Raloxifene Hydrochloride